Mainstreaming Addiction Treatment Act of 2019
United States116th CongressHR-2482House of Representatives
Updated: May 31, 2019
Summary
Mainstreaming Addiction Treatment Act of 2019 This bill removes the requirement that a health care practitioner apply for a separate waiver through the Drug Enforcement Administration to dispense certain narcotic drugs (e.g., buprenorphine) for maintenance or detoxification treatment (i.e., substance use disorder treatment). Further, the bill directs the Substance Abuse and Mental Health Services Administration to conduct a national campaign to educate health care practitioners and encourage them to integrate substance use disorder treatment into their practices.
Bill texts
All available records shown.
Timeline
Latest companion bill action
S-2074: Mainstreaming Addiction Treatment Act of 2019Introduced in Senate
Introduced in House
Referred to the Committee on Energy and Commerce, and in addition to the Committees on the Judiciary, and Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
House of Representatives
Referred to the Subcommittee on Health.
House of Representatives
Referred to the Subcommittee on Crime, Terrorism, and Homeland Security.
House of Representatives
All available records shown.